| Primary |
| Infection |
16.2% |
| Staphylococcal Bacteraemia |
13.2% |
| Bacteraemia |
10.3% |
| Endocarditis |
10.3% |
| Osteomyelitis |
8.8% |
| Cellulitis |
5.9% |
| Staphylococcal Infection |
5.9% |
| Arthritis Bacterial |
4.4% |
| Endocarditis Staphylococcal |
4.4% |
| Hypertension |
2.9% |
| Staphylococcal Abscess |
2.9% |
| Wound Infection |
2.9% |
| Analgesic Therapy |
1.5% |
| Antibiotic Prophylaxis |
1.5% |
| Cellulitis Staphylococcal |
1.5% |
| Central Nervous System Abscess |
1.5% |
| Enthesopathy |
1.5% |
| Gram Stain Positive |
1.5% |
| Hip Fracture |
1.5% |
| Lung Abscess |
1.5% |
|
| Tubulointerstitial Nephritis |
34.5% |
| Rash |
12.1% |
| Renal Failure Acute |
8.6% |
| Hypokalaemia |
5.2% |
| Vomiting |
5.2% |
| Blood Potassium Decreased |
3.4% |
| Platelet Count Decreased |
3.4% |
| Pyrexia |
3.4% |
| Respiratory Arrest |
3.4% |
| White Blood Cell Count Decreased |
3.4% |
| Anaphylactic Reaction |
1.7% |
| Blood Bilirubin Increased |
1.7% |
| Blood Creatinine Increased |
1.7% |
| Cholestasis |
1.7% |
| Clostridium Test Positive |
1.7% |
| Dehydration |
1.7% |
| Dermatitis Bullous |
1.7% |
| Diarrhoea |
1.7% |
| Drug Hypersensitivity |
1.7% |
| Erythema Multiforme |
1.7% |
|
| Secondary |
| Product Used For Unknown Indication |
19.0% |
| Staphylococcal Infection |
8.7% |
| Corynebacterium Infection |
8.1% |
| Enterobacter Infection |
8.1% |
| Enterococcal Infection |
8.1% |
| Staphylococcal Bacteraemia |
8.1% |
| Streptococcal Infection |
8.1% |
| Pulmonary Arterial Hypertension |
4.9% |
| Pain |
4.3% |
| Agitation |
2.7% |
| Rheumatoid Arthritis |
2.7% |
| Cellulitis |
2.4% |
| Dementia |
2.4% |
| Gastrooesophageal Reflux Disease |
2.4% |
| Graft Infection |
2.2% |
| Hypertension |
1.9% |
| Asthma |
1.6% |
| Constipation |
1.4% |
| Hypothyroidism |
1.4% |
| Thrombosis Prophylaxis |
1.4% |
|
| Vomiting |
16.7% |
| Respiratory Failure |
11.1% |
| Renal Failure Acute |
8.3% |
| Blood Potassium Decreased |
5.6% |
| Lower Gastrointestinal Haemorrhage |
5.6% |
| Medication Error |
5.6% |
| Mental Disorder |
5.6% |
| Nelson's Syndrome |
5.6% |
| Vessel Puncture Site Haematoma |
5.6% |
| Atrial Flutter |
2.8% |
| Chills |
2.8% |
| Clostridium Test Positive |
2.8% |
| Dyspnoea |
2.8% |
| Encephalopathy |
2.8% |
| Hepatitis Cholestatic |
2.8% |
| Hypotension |
2.8% |
| Inhibitory Drug Interaction |
2.8% |
| International Normalised Ratio Increased |
2.8% |
| Irritability |
2.8% |
| Platelet Count Decreased |
2.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
48.5% |
| Staphylococcal Bacteraemia |
8.2% |
| Lymphocytic Leukaemia |
6.0% |
| Aortic Valve Replacement |
4.9% |
| Drug Use For Unknown Indication |
4.4% |
| Endocarditis |
3.6% |
| Sepsis |
3.6% |
| Coronary Artery Bypass |
2.7% |
| Staphylococcal Infection |
2.2% |
| Empyema |
1.9% |
| Mitral Valve Replacement |
1.9% |
| Bacteraemia |
1.6% |
| Pain |
1.6% |
| Acute Myeloid Leukaemia |
1.4% |
| Nausea |
1.4% |
| Nuclear Magnetic Resonance Imaging |
1.4% |
| Sedation |
1.4% |
| Angiogram |
1.1% |
| Mantle Cell Lymphoma |
1.1% |
| Thrombosis Prophylaxis |
1.1% |
|
| Renal Failure |
7.4% |
| Unevaluable Event |
7.4% |
| Anhedonia |
5.6% |
| Anxiety |
5.6% |
| Fear |
5.6% |
| Injury |
5.6% |
| Opiates Positive |
5.6% |
| Pain |
5.6% |
| Renal Failure Acute |
5.6% |
| Stress |
5.6% |
| Tinnitus |
5.6% |
| Vomiting |
5.6% |
| Cardiogenic Shock |
3.7% |
| Death |
3.7% |
| Drug Exposure During Pregnancy |
3.7% |
| Feeling Abnormal |
3.7% |
| Intervertebral Discitis |
3.7% |
| Rash Generalised |
3.7% |
| Right Ventricular Failure |
3.7% |
| Urinary Tract Infection Enterococcal |
3.7% |
|
